Longitudinal assessment of cognitive function in patients with breast cancer and lymphoma receiving chemotherapy
JNCI Cancer Spectrum · 2025
DOI: 10.1093/jncics/pkaf105 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2025. Verfasst von Hongying Sun und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Rochester, NY, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphoma, Cognition, Cognitive Dysfunction. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Cancer-related cognitive impairment is a significant concern, yet data assessing long-term changes from pretreatment baselines are limited.
Methods
In this large nationwide study, patients with breast cancer and lymphoma and controls were assessed at pre-chemotherapy, post-chemotherapy, 6-month, 1-year, and 2-year follow-ups. Cognitive function was measured using self-reported and performance-based assessments. The analysis included 225 participants: breast cancer (41 patients/36 controls) and lymphoma (73 patients/75 controls). Cognitive trajectories were estimated using longitudinal linear mixed models, adjusting for demographic, clinical, and psychosocial factors. A minimal clinically important difference cutoff identified changes over time in perceived cognitive impairment.
Results
Patients with breast cancer reported greater cognitive complaints than controls, with declines in FACT-Cog Total (β = −17.17, P < .001), Perceived Cognitive Impairment (β = −11.09, P < .001), and Perceived Cognitive Abilities (β = −3.60, P = .03) from pre-chemotherapy to 2-year follow-up. Declines were observed in memory (Rey Auditory Verbal Learning Test [RAVLT] Immediate Recall: β = −1.53, P = .04) and executive function (phone fluency: β = −1.53, P = .02) at 1 year. Patients with lymphoma also showed more complaints, with declines in Perceived Cognitive Impairment (β = −6.19, P = .01), poorer RAVLT Immediate (β = −1.62, P < .001), Delayed Recall (β = −1.72, P < .001), and phone fluency (β = −2.46, P < .001) from pre-chemotherapy to 1-year follow-up.
Conclusion
Compared with controls, patients with breast cancer and lymphoma showed persistent cognitive worsening up to 1-year posttreatment, and patients with breast cancer reported perceived impairment at 2 years compared with controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Rochester, NY, United States.
- Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, United States.
- Upstate Carolina National Cancer Institute Community Oncology Research Program, Spartanburg Regional Medical Center, Spartanburg, SC, United States.
- Heartland Cancer Research National Cancer Institute Community Oncology Research Program, Peoria, IL, United States.
- Delaware/Christiana Care National Cancer Institute Community Oncology Research Program, Helen Graham Cancer Center, Newark, DE, United States.
- Division of Hematology and Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, United States.
ORCID-Profile: Hongying Sun, Umang Gada, Riham Alieldin, Tianming Zhao, Hannah Teets, James D Bearden, Jamal Misleh, Kah Poh Loh, Allison Magnuson, Mostafa R Mohamed, Nikesha Gilmore, Timothy B Winslow, Annalynn M Williams, Chin-Shang Li, Michelle C Janelsins
Förderung
- NCI NIH HHS
Zitieren
APA
Sun, H., Gada, U., Alieldin, R., Zhao, T., Teets, H., Bearden, J. D., Esparaz, B. T., Misleh, J., Loh, K. P., Magnuson, A., Mohamed, M. R., Gilmore, N., Winslow, T. B., Williams, A. M., Li, C. S., & Janelsins, M. C. (2025). Longitudinal assessment of cognitive function in patients with breast cancer and lymphoma receiving chemotherapy. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf105
Vancouver
Sun H, Gada U, Alieldin R, Zhao T, Teets H, Bearden JD, et al. Longitudinal assessment of cognitive function in patients with breast cancer and lymphoma receiving chemotherapy. JNCI Cancer Spectrum. 2025. doi:10.1093/jncics/pkaf105
BibTeX
@article{Sun2025,
author = {Sun, Hongying and Gada, Umang and Alieldin, Riham and Zhao, Tianming and Teets, Hannah and Bearden, James D and Esparaz, Benjamin T and Misleh, Jamal and Loh, Kah Poh and Magnuson, Allison and Mohamed, Mostafa R and Gilmore, Nikesha and Winslow, Timothy B and Williams, Annalynn M and Li, Chin-Shang and Janelsins, Michelle C},
title = {Longitudinal assessment of cognitive function in patients with breast cancer and lymphoma receiving chemotherapy},
journal = {JNCI Cancer Spectrum},
year = {2025},
doi = {10.1093/jncics/pkaf105}
}
EUVIMED